EULAR recommendations for the management of systemic lupus erythematosus: 2023 update Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang-Cheol Bae, John Boletis, Ian N Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, Richard A Furie, Dafna D Gladman, Frederic A Houssiau, Luís Sousa InêsSee the full list of authors
2 January 2024
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update Bernhard Hellmich, Beatriz Sanchez-Alamo, Jan H Schirmer, Alvise Berti, Daniel Blockmans, Maria C Cid, Julia U Holle, Nicole Hollinger, Omer Karadag, Andreas Kronbichler, Mark A Little, Raashid A Luqmani, Alfred Mahr, Peter A Merkel, Aladdin J MohammadSee the full list of authors
2 January 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd R Burmester, Juan D CañeteSee the full list of authors
15 May 2024
Long COVID: a new word for naming fibromyalgia? Xavier Mariette
2 January 2024
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update Tuva Moseng, Theodora P M Vliet Vlieland, Simone Battista, David Beckwée, Vladimira Boyadzhieva, Philip G Conaghan, Daniela Costa, Michael Doherty, Andrew G Finney, Tsvetoslav Georgiev, Milena Gobbo, Norelee Kennedy, Ingvild Kjeken, Féline P B Kroon, L Stefan LohmanderSee the full list of authors
15 May 2024
2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice Peter Mandl, Maria Antonietta D’Agostino, Victoria Navarro-Compán, Irina Geßl, Garifallia Sakellariou, Abhishek Abhishek, Fabio Becce, Nicola Dalbeth, Hang-Korng Ea, Emilio Filippucci, Hilde Berner Hammer, Annamaria Iagnocco, Annette de Thurah, Esperanza Naredo, Sebastien OttavianiSee the full list of authors
15 May 2024
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update Christian Dejaco, Sofia Ramiro, Milena Bond, Philipp Bosch, Cristina Ponte, Sarah Louise Mackie, Thorsten A Bley, Daniel Blockmans, Sara Brolin, Ertugrul Cagri Bolek, Rebecca Cassie, Maria C Cid, Juan Molina-Collada, Bhaskar Dasgupta, Berit Dalsgaard NielsenSee the full list of authors
15 May 2024
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story Michael Bonelli, Andreas Kerschbaumer, Kastriot Kastrati, Kamran Ghoreschi, Massimo Gadina, Leonhard X Heinz, Josef S Smolen, Daniel Aletaha, John O'Shea, Arian Laurence
11 January 2024
EULAR/PReS recommendations for the diagnosis and management of Still’s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still’s disease Bruno Fautrel, Stéphane Mitrovic, Arianna De Matteis, Sara Bindoli, Jordi Antón, Alexandre Belot, Claudia Bracaglia, Tamàs Constantin, Lorenzo Dagna, Alessandro Di Bartolo, Eugen Feist, Dirk Foell, Marco Gattorno, Sophie Georgin-Lavialle, Roberto GiacomelliSee the full list of authors
14 November 2024
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial Di Wu, Jing Li, Dong Xu, Joan T Merrill, Ronald F van Vollenhoven, Yi Liu, Jiankang Hu, Yang Li, Fen Li, Chenghui Huang, Guochun Wang, Xiaomei Li, Jianhong Zhao, Dongbao Zhao, Cibo HuangSee the full list of authors
12 March 2024
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis Ioannis Parodis, Charlotte Girard-Guyonvarc’h, Laurent Arnaud, Oliver Distler, Andrea Domján, Cornelia H M Van den Ende, Kim Fligelstone, Agnes Kocher, Maddalena Larosa, Martin Lau, Alexandros Mitropoulos, Mwidimi Ndosi, Janet L Poole, Anthony Redmond, Valentin RitschlSee the full list of authors
15 May 2024
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial Duvuru Geetha, Anisha Dua, Huibin Yue, Jason Springer, Carlo Salvarani, David Jayne, Peter Merkel
11 January 2024
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases Emma Dures, Bayram Farisoğulları, Eduardo José Ferreira Santos, Anna Molto, Caroline Feldthusen, Claire Harris, Corinna Elling-Audersch, Deirdre Connolly, Elena Elefante, Fernando Estévez-López, Ilaria Bini, Jette Primdahl, Kirsten Hoeper, Marie Urban, Mart A F J van de LaarSee the full list of authors
30 September 2024
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study) Romain Aymon, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Diederik De Cock, Lene Dreyer, Ori Elkayam, Doreen Huschek, Kimme L Hyrich, Florenzo Iannone, Nevsun Inanc, Lianne Kearsley-Fleet, Suleyman Serdar KOCA, Tore K KvienSee the full list of authors
12 March 2024
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications Mark D Russell, Christopher Stovin, Edward Alveyn, Olukemi Adeyemi, Chun Kit David Chan, Vishit Patel, Maryam A Adas, Fabiola Atzeni, Kenrick K H Ng, Andrew I Rutherford, Sam Norton, Andrew P Cope, James B Galloway
28 February 2024
Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial Reza Zonozi, Frank B Cortazar, Anushya Jeyabalan, Gabriel Sauvage, Pravarut Nithagon, Noah R Huizenga, Jillian M Rosenthal, Alexander Sipilief, Katherine Cosgrove, Karen A Laliberte, Eugene P Rhee, William F Pendergraft, III, John L Niles
15 February 2024
Novel autoantibodies help diagnose anti-SSA antibody negative Sjögren disease and predict abnormal labial salivary gland pathology Maxwell Parker, Zihao Zheng, Michael R Lasarev, Michele C Larsen, Addie Vande Loo, Roxana A Alexandridis, Michael A Newton, Miriam A Shelef, Sara S McCoy
27 August 2024
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis Andreas Kerschbaumer, Josef S Smolen, Ricardo J O Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Jan W Schoones, Laure Gossec
15 May 2024
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren’s syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial Thomas Dörner, Martin Kaul, Antónia Szántó, Jui-Cheng Tseng, Athena S Papas, Ilona Pylvaenaeinen, Malika Hanser, Nasri Abdallah, Andrea Grioni, Aida Santos Da Costa, Enrico Ferrero, Peter Gergely, Rainer Hillenbrand, Alexandre Avrameas, Bruno CenniSee the full list of authors
15 February 2024
What rheumatologists need to know about mRNA vaccines: current status and future of mRNA vaccines in autoimmune inflammatory rheumatic diseases Jin Kyun Park, Eun Bong Lee, Kevin L Winthrop
15 May 2024